SHAREHOLDER ALERT The Gross Law Firm Notifies Shareholders of Brainstorm Cell Therapeutics Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2024 -

BCLI Stock  USD 1.73  0.02  1.17%   
Under 61% of Brainstorm Cell's investor base is looking to short. The analysis of the overall investor sentiment regarding Brainstorm Cell Therapeutics suggests that many traders are alarmed. Brainstorm Cell's investing sentiment shows overall attitude of investors towards Brainstorm Cell Therapeutics.
  
SHAREHOLDER ALERT The Gross Law Firm Notifies Shareholders of Brainstorm Cell Therapeutics Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2024 - Published Nov. 21, 2023 at 1245 AM HST Updated 7 minutes

Read at hawaiinewsnow.com
news
  

Brainstorm Cell Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Brainstorm Cell can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Brainstorm Cell Fundamental Analysis

We analyze Brainstorm Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brainstorm Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brainstorm Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Liabilities

Current Liabilities Comparative Analysis

Brainstorm Cell is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Brainstorm Cell Ther Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brainstorm Cell stock to make a market-neutral strategy. Peer analysis of Brainstorm Cell could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics with similar companies.

Peers

Brainstorm Cell Related Equities

TERNTerns Pharmaceuticals   11.32   
0%
71.0%
GRIGRI Bio   3.08   
0%
19.0%
XFORX4 Pharmaceuticals   2.70   
0%
17.0%
INZYInozyme Pharma   2.67   
0%
16.0%
DAWNDay One   1.55   
0%
9.0%
BCABBioatla   1.26   
0%
8.0%
CKPTCheckpoint Therapeutics   0.99   
0%
6.0%
CNTBConnect Biopharma   0.90   
0%
5.0%
EWTXEdgewise Therapeutics   0.31   
0%
1.0%
MREOMereo BioPharma   0.28   
0%
1.0%
PLXProtalix Biotherapeutics   0.61   
3.0%
0%
ANTXAN2 Therapeutics   0.67   
4.0%
0%
CELCCelcuity LLC   0.71   
4.0%
0%
GBIOGeneration Bio   0.73   
4.0%
0%
ALDXAldeyra   1.66   
10.0%
0%
CUECue Biopharma   2.56   
16.0%
0%
CRVSCorvus Pharmaceuticals   3.02   
19.0%
0%
CCCCC4 Therapeutics   3.69   
23.0%
0%
HOWLWerewolf Therapeutics   4.84   
30.0%
0%
TRVITrevi Therapeutics   6.47   
41.0%
0%
HCWBHCW Biologics   8.70   
55.0%
0%
PASGPassage Bio   15.73   
100.0%
0%

Complementary Tools for Brainstorm Stock analysis

When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets